This invention relates to 5-chloro-2, 3-dihydro-2,2-dimethylbenzofuran-7-carboxy lic acid-octahydro-3-hydroxy-2,6-metha-no-2H-quinolizin-8-yl ester (I), a novel 5-HT3-receptor antagonist, its method of preparation, and to its end-use application in the treatment of radio- and chemo-therapeutically-induced nausea and vomiting, in the treatment of pain associated with migraine, in the treatment of cognitive disorders, in treating hallucinatory endogenous psychoses of the type manifested in patients suffering from schizophrenia and mania, for irritable bowel syndrome, and to combat drug abuse.
2,6-METHANO-2H-QUINOLIZIN DERIVATIVE AS 5-HT3-RECEPTOR ANTAGONIST